PK en therapietrouw bij HIV
- Universiteit Rijksuniversiteit Groningen
- Promovendus Zamrotul Izzah
- Promoters Prof. dr. D.J. Touw
- Co-Promoters ds dr. Christoffer Aberg
- Jaar 2019 - 2023
Ontwikkelen van analytische tools om therapietrouw te monitoren.
Ontwikkelen van analytische tools om therapietrouw te monitoren.
Onderzoek in Spanje
Het onderzoek is gericht op het verbeteren van immuunsupressieve therapie bij niertransplantatiepatiƫnten met behulp van PK-PD modelling.
Onderzoek in India
The landscape of drug development as well as clinical practice has been changing over the last decennium, with the increasing availability and use of biobased therapies. This research is now focusing on the use and therapeutic drug monitoring of biobased factor VIII therapies in hemophilia A patients.
Use population PK/PD modeling approach and consider evolving resistance development to better understand the development of drug resistance in anti-cancer treatments and to optimize and individualize anti-cancer treatment.